235 results
DEFA14A
ABT
Abbott Laboratories
15 Mar 24
Additional proxy soliciting materials
4:04pm
. We encourage you to access and review all of the important information contained in the proxy materials before voting. The 2024 proxy statement … and 2023 annual report to shareholders are available at:
www.investorvote.com/abt
Easy Online Access — View your proxy materials and vote.
Step 1:
Go
8-K
EX-99.1
ABT
Abbott Laboratories
18 Oct 23
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7:37am
biotech leader mAbxience Holdings S.L. to commercialize several biosimilar molecules, with the goal of broadening access to these therapies for people
8-K
EX-3.1
nivzfllsgp uu1qyyw4
9 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
EX-3.1
w1be7jy35365kjdhbv0
15 Sep 22
Departure of Directors or Certain Officers
4:03pm
PX14A6G
bht ww5ana7t
24 Mar 22
Letter to shareholders
3:51pm
DEFA14A
ceydoi0 ut
18 Mar 22
Additional proxy soliciting materials
4:27pm
8-K
EX-3.1
2c7zl0m9v3
22 Feb 22
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
EX-3.1
khl5d1 8gii071p
10 Dec 21
Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as Executive Chairman
4:34pm
8-K
EX-3.1
vv9r45rss8p4 x9y
1 Sep 21
Departure of Directors or Certain Officers
7:11am
DEFA14A
4htm6tnpg 1dnjxw
12 Mar 21
Additional proxy soliciting materials
4:21pm
8-K
EX-3.1
z80vt fb65rampkgtxm
19 Feb 21
Departure of Directors or Certain Officers
4:23pm